Your browser doesn't support javascript.
loading
Incidence and Risk Factors of Immediate Hypersensitivity Reactions Associated With Low-Osmolar Iodinated Contrast Media: A Longitudinal Study Based on a Real-Time Monitoring System.
Lee, S Y; Kang, D Y; Kim, J Y; Yoon, S H; Choi, Y H; Lee, W; Cho, S H; Kang, H R.
Afiliación
  • Lee SY; Institute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul, Korea.
  • Kang DY; Division of Allergy and Clinical Immunology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
  • Kim JY; Drug Safety Monitoring Center, Seoul National University Hospital, Seoul, Korea.
  • Yoon SH; Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Changwon, Korea.
  • Choi YH; Department of Radiology, Seoul National University College of Medicine, Seoul, Korea.
  • Lee W; Department of Radiology, Seoul National University College of Medicine, Seoul, Korea.
  • Cho SH; Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Changwon, Korea.
  • Kang HR; Institute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul, Korea.
J Investig Allergol Clin Immunol ; 29(6): 444-450, 2019.
Article en En | MEDLINE | ID: mdl-30676320
OBJECTIVES: We investigated the incidence of immediate hypersensitivity reaction (HSR) caused by different types of low-osmolar contrast media (LOCM) and cumulative exposure to LOCM. METHODS: This cohort study included all consecutive patients who underwent LOCM-enhanced computed tomography from 2012 through 2014. We assessed 5 LOCM (iobitridol, iohexol, iomeprol, iopamidol, and iopromide). All patients were monitored for adverse events, and new symptoms and signs were recorded in real time using the Contrast Safety Monitoring and Management System (CoSM2oS). RESULTS: The overall incidence of immediate HSR to LOCM was 0.97% (2004 events resulting from 205 726 exposures). Incidence differed significantly depending on whether the patient had a previous history of HSR to LOCM (0.80% in patients with no history and 16.99% in patients with a positive history of HSR to LOCM, P=.001). The incidence of HSR to individual LOCM ranged from 0.72% (iohexol) to 1.34% (iomeprol), although there were no significant differences across the 5 LOCM. A longitudinal analysis demonstrated that the incidence of HSR increased gradually with more frequent previous exposure to LOCM (HR=2.006 [95%CI, 1.517-2.653], P<.001). However, this cumulative increase in risk was observed in patients who had experienced HSR to LOCM, but not in those who had not. CONCLUSION: The incidence of HSR did not differ significantly across the 5 LOCM assessed in the study. Repeated exposure to LOCM did not increase the risk of HSR among patients who had never experienced HSR to LOCM.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ácidos Triyodobenzoicos / Medios de Contraste / Hipersensibilidad a las Drogas / Hipersensibilidad Inmediata Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: J Investig Allergol Clin Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2019 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ácidos Triyodobenzoicos / Medios de Contraste / Hipersensibilidad a las Drogas / Hipersensibilidad Inmediata Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: J Investig Allergol Clin Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2019 Tipo del documento: Article